- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
November 4, 2020
Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma.
November 4, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.
November 3, 2020
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.
November 3, 2020
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
November 2, 2020
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery.
November 2, 2020
Long non-coding RNAs and renal cell carcinoma.
October 30, 2020
Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.
October 30, 2020
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer.
October 29, 2020
Stereotactic radiotherapy combined with immune- or targeted therapy for metastatic renal cell carcinoma.
October 29, 2020
Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
October 28, 2020
Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials.
October 28, 2020
Differentiation of renal cell tumors with morphological cocktails using a minimal panel of immunohistochemical markers.
October 28, 2020